Deal propels Abbott to big job in India with pharmaceutical sales expected to exceed $2.5 billion by 2020 ABBOTT PARK, Ill., Sept. 8 (HSMN NewsFeed) — Abbott (NYSE:ABT ) has completed its acquisition of Piramal’s Healthcare Solutions business, p…
Biopharmaceuticals, Mergers & Acquisitions
Abbott, Piramal

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Abbott Completes Acquisition of Piramal’s Healthcare Solutions Business, Becomes Big Clinical Company in India”
Leave a Comment